These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34611630)

  • 1. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.
    Xiao J; Dai J; Hu J; Liu T; Gong D; Li X; Kang M; Zhou Y; Li Y; Quan Y; He G; Zhong R; Zhu Z; Huang Q; Zhang Y; Huang J; Du Q; Li Y; Song T; Hu W; Zhong H; Ma W
    Lancet Reg Health West Pac; 2021 Dec; 17():100282. PubMed ID: 34611630
    [No Abstract]   [Full Text] [Related]  

  • 2. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19.
    Chen B; Wang M; Huang X; Xie M; Pan L; Liu H; Liu Z; Zhou P
    Front Public Health; 2021; 9():728768. PubMed ID: 34722440
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.
    Hung SH; Lin WT; Wang JH; Lai CC
    J Infect Public Health; 2022 Sep; 15(9):1001-1005. PubMed ID: 35981407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different levels of non-pharmaceutical interventions on hand, foot and mouth disease in Guangzhou, China.
    Wu K; Ma X; Liu H; Zheng J; Zhou R; Yuan Z; Huang Z; Zhong Q; Huang Y; Zhang Z; Wu X
    BMC Public Health; 2022 Dec; 22(1):2398. PubMed ID: 36539790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China.
    Shen L; Sun M; Song S; Hu Q; Wang N; Ou G; Guo Z; Du J; Shao Z; Bai Y; Liu K
    J Med Virol; 2022 Jul; 94(7):3121-3132. PubMed ID: 35277880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.
    Li K; Rui J; Song W; Luo L; Zhao Y; Qu H; Liu H; Wei H; Zhang R; Abudunaibi B; Wang Y; Zhou Z; Xiang T; Chen T
    Nat Commun; 2024 May; 15(1):3891. PubMed ID: 38719858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Transmission Dynamics of Coronavirus Disease 2019 (COVID-19) and Influenza Suggest the Relative Efficiency of Isolation/Quarantine and Social Distancing Against COVID-19 in China.
    Lei H; Wu X; Wang X; Xu M; Xie Y; Du X; Cowling BJ; Li Y; Shu Y
    Clin Infect Dis; 2021 Dec; 73(11):e4305-e4311. PubMed ID: 33080000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of morbidity and mortality characteristics of the notifiable diseases reported in 2013 in China].
    Wang L; Zeng L; Ren X; Geng M; Li Z; Yu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):194-8. PubMed ID: 25975392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic.
    Geng MJ; Zhang HY; Yu LJ; Lv CL; Wang T; Che TL; Xu Q; Jiang BG; Chen JJ; Hay SI; Li ZJ; Gao GF; Wang LP; Yang Y; Fang LQ; Liu W
    Nat Commun; 2021 Nov; 12(1):6923. PubMed ID: 34836947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.
    Lai CC; Chen SY; Yen MY; Lee PI; Ko WC; Hsueh PR
    Travel Med Infect Dis; 2021; 40():101997. PubMed ID: 33640476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.
    Ullrich A; Schranz M; Rexroth U; Hamouda O; Schaade L; Diercke M; Boender TS;
    Lancet Reg Health Eur; 2021 Jul; 6():100103. PubMed ID: 34557831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between COVID-19 Infection and Risk Perception, Knowledge, Attitude, and Four Nonpharmaceutical Interventions During the Late Period of the COVID-19 Epidemic in China: Online Cross-Sectional Survey of 8158 Adults.
    Xu H; Gan Y; Zheng D; Wu B; Zhu X; Xu C; Liu C; Tao Z; Hu Y; Chen M; Li M; Lu Z; Chen J
    J Med Internet Res; 2020 Nov; 22(11):e21372. PubMed ID: 33108317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.